<rp id="ud5os"></rp>
<th id="ud5os"><track id="ud5os"></track></th>

<button id="ud5os"></button>
  • <th id="ud5os"><pre id="ud5os"><sup id="ud5os"></sup></pre></th>

  • 歡迎訪問成都樂美天醫藥科技有限公司

    Royal society of chemistry-12 Mar 2020

    發布時間:2022-08-06
    作者:未知
    閱讀次數:331
    文章字數:1745

    The development and validation of an HPLC-MS/MS method for the determination of eriocitrin in rat plasma and its application to a pharmacokinetic study

    期刊名:RSC Advances
    文獻編號:DOI 10.1039/C9RA10925K
    文獻地址:https://pubs.rsc.org/en/content/articlelanding/2020/RA/C9RA10925K#!divAbstract
    發表日期:12 Mar 2020


    Abstract

    Eriocitrin is one of the major active constituents of lemon fruit, and it possesses strong antioxidant, lipid-lowering, anticancer and anti-inflammatory activities and has long been used in food, beverages and wine. In this study, for the first time, a rapid, selective, and sensitive liquid chromatography-tandem mass spectrometry method (LC/MS/MS) with protein precipitation was developed and validated for the analysis of eriocitrin in rat plasma. Chromatographic separation was achieved using a mobile phase, comprising 0.1% formic acid aqueous solution and acetonitrile eluted at a flow rate of 0.8 mL min−1. In multiple reaction monitoring (MRM) modes, eriocitrin and internal standard (IS) were quantified using precursor-to-product ion transitions of m/z 595.4 → 287.1 and m/z 252.0 → 155.9, respectively. The intra- and inter-day precision (RSD) were below 6.79% in plasma, while accuracy (RE) was within ±7.67%. The matrix effect, recovery and stability were also demonstrated to be within acceptable limits. This method was successfully employed in the pharmacokinetic study on rats after the oral administration of eriocitrin. The pharmacokinetic parameters show that the maximum plasma concentration (Cmax) of eriocitrin was 299.833 ± 16.743 μg L−1, while the corresponding time to reach Cmax(Tmax) was 0.094 ± 0.019 h, and the half-time (T1/2) was 1.752 ± 0.323 h. The present results would be valuable for further research and development of eriocitrin.

    Eriocitrin (13463-28-0, purity > 98.5%) was obtained from Chengdu Desite Biological Technology Co., Ltd (Chengdu, China)

    相關文章 產品推薦
    QQ咨詢
    售前咨詢:
    售前咨詢:
    代理合作:
    集采合作: 點擊這里給我發消息
    久久精品国产99久久久_性xxxx欧美老妇胖老太肥肥_欧美l日韩国产一级视频_日本亚洲欧洲色a久久 <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <文本链> <文本链> <文本链> <文本链> <文本链> <文本链>